Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Enanta Pharmaceutica
(NQ:
ENTA
)
12.20
-0.06 (-0.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enanta Pharmaceutica
< Previous
1
2
3
4
5
6
7
Next >
Can Anyone Challenge Pfizer's Covid Dominance? Why These Biotechs Say Yes
February 11, 2022
Drug behemoth Pfizer was the first to launch a Covid antiviral pill — but a pack of small biotech stocks are already nipping at its heels.
Via
Investor's Business Daily
Enanta Pharmaceuticals to Present at the SVB Leerink 11th Annual Global Healthcare Conference
February 10, 2022
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Where Enanta Pharmaceuticals Stands With Analysts
February 09, 2022
Enanta Pharmaceuticals (NASDAQ:ENTA) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Enanta Pharmaceuticals: Q1 Earnings Insights
February 08, 2022
Enanta Pharmaceuticals (NASDAQ:ENTA) reported its Q1 earnings results on Tuesday, February 8, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET
February 08, 2022
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Expert Ratings For Enanta Pharmaceuticals
November 08, 2021
Enanta Pharmaceuticals (NASDAQ:ENTA) has observed the following analyst ra...
Via
Benzinga
Earnings Scheduled For February 8, 2022
February 08, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
Via
Benzinga
Enanta Pharmaceuticals to Host Conference Call on February 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2021
February 01, 2022
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
What 10 Analyst Ratings Have To Say About Enanta Pharmaceuticals
January 13, 2022
Analysts have provided the following ratings for Enanta Pharmaceuticals (NASDAQ:
Via
Benzinga
10 Biggest Price Target Changes For Thursday
January 13, 2022
RBC Capital boosted KB Home (NYSE: KBH) price target from $46 to $55. KB Home shares rose 6.7% to $45.20 in pre-market trading. Cowen & Co. reduced the price target on...
Via
Benzinga
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Outlook for 2022 at the 40th Annual J.P. Morgan Healthcare Conference
January 06, 2022
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
7 A-Rated Biotechs to Buy for the Long Run
December 03, 2021
The one thing the pandemic has shown us is biotechs are changing the way we treat diseases. These A-rated biotechs are great examples.
Via
InvestorPlace
Where Enanta Pharmaceuticals Stands With Analysts
November 24, 2021
Over the past 3 months, 11 analysts have published their opinion on Enanta Pharmaceuticals (NASDAQ:
Via
Benzinga
Enanta Pharmaceuticals, inc (ENTA) Q4 2021 Earnings Call Transcript
November 22, 2021
ENTA earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET
November 22, 2021
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
56 Biggest Movers From Yesterday
November 24, 2021
Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating...
Via
Benzinga
Earnings Scheduled For November 22, 2021
November 22, 2021
Companies Reporting Before The Bell • Cerence (NASDAQ:CRNC) is estimated to report quarterly earnings at $0.56 per share on revenue of $97.92 million. • Avaya...
Via
Benzinga
52 Biggest Movers From Friday
November 22, 2021
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares surged 90.2% to close at $9.89 on Friday. Greenland Technologies highlighted the launch of second...
Via
Benzinga
The Week Ahead In Biotech (Nov. 21-Nov. 27): FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
November 21, 2021
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting...
Via
Talk Markets
Exposures
Product Safety
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
November 21, 2021
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
November 19, 2021
Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares...
Via
Benzinga
Enanta Pharmaceuticals's Earnings: A Preview
November 19, 2021
Enanta Pharmaceuticals (NASDAQ:ENTA) is set to give its latest quarterly earnings report on Monday, 2021-11-22. Here's what investors need to know before the announcement....
Via
Benzinga
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
November 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Connect Biopharma Atopic Dermatitis Treatment Aces Mid-stage Study But Lack...
Via
Benzinga
Safety Signals Force Enanta To Stop EDP-721 HBV Program
November 19, 2021
Enanta Pharmaceuticals Inc (NASDAQ: ENTA) has decided to discontinue the development of EDP-721, an oral Hepatitis B Virus (HBV) RNA destabilizer. The move follows...
Via
Benzinga
Enanta Pharmaceuticals to Participate in December Investor Conferences
November 19, 2021
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces Update to its Hepatitis B Virus (HBV) Program
November 18, 2021
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Host Conference Call on November 22 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2021
November 15, 2021
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Reports Positive Final Data from its Phase 1b Studies of EDP-514, a Novel Hepatitis B Virus Core Inhibitor
November 12, 2021
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.